1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island

370

companies

as of February 29, 2024

Companies are divided into categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the minor field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

You can select the initial.

CAE Solution Corporation. Focus Technical Center

Major field:IT

Development, sale and consulting of various CAE software

Overview

As a leading company in analysis software in Japan, we are engaged in sales of analysis software, training of analysis software, technical support of analytical software, contract analysis analysis and consignment development.
For everyone who uses analysis software in Japan, we provide all kinds of technology to make smooth use.

Product / Service / PR

    We handle various analysis software, such as heat, fluid, structure, resin, signal processing, sound, electromagnetic field, fire and evacuation.
    In addition, we are introducing Open Souse CAE as well as commercial software and CROUD CAE, uses analysis environment with external calculation resources.
Address: Computational Science Center Bldg 2F, 7-1-28, Minatoshima Minami-machi, Chuo-ku, Kobe-shi, Hyogo-ken, 650-0047, Japan  (Contact Person Hiroyuki TAKURA)
TEL: +81-78-303-3558 FAX: +81-78-303-3559
Web site: https://www.cae-sc.com/ E-mail: focus@cae-sc.com

CarbGeM Inc.

Major field:Outsourcing Business for Hospital

Miner field:Medical Equipment

Miner field:IT

Overview

Antibiotic resistance is a growing public health concern worldwide and is caused by misuse and overuse of antibiotics that are used for treating infections caused by bacteria.
We created Bitte to help clinicians to identify the type of bacteria which infected patients and chose appropriate antibiotics for better patient outcome. For more details, visit

Product / Service / PR

    Point of Care Gram Staining (PoCGS):
    Stain the patient sample on a slide glass and set it in PoCGS to complete the stained sample in a short time (10 minutes). The sample type(urine, sputum, etc.), reagent titration amount, staining time, etc. can be changed on the operation panel.
    https://carbgem.com/en/product-en/pocgs-ie-en/

    Application for estimating bacterial species in bacterial infections & Appropriate antibiotic selection support system BiTTE:
    This system supports highly accurate bacterial species estimation using AI image recognition technology for Gram stain images, and the selection of appropriate antibiotics connecting with antibiograms.
    https://carbgem.com/en/product-en/bitte-ie-en/
Address: 1-5-13 Jinnan, Shibuya-ku, Tokyo 150-0041, Japan  (Contact Person Rie Toyoda)
TEL: 03-6431-8148
Web site: https://carbgem.com/en/ E-mail: info@carbgem.com

Cardio Inc.

Major field:Medical Equipment

R&D of cardiovascular regenerative medicine

Overview

We research and develop medical devices to treat the cardiac diseases and health care products which are based on the research of regenerative medicine. We also do the import and sale business of medical devices.

Product / Service / PR

    The section of R&D Medical Device : 「Quad Holder」 is on the market, and several devices are under development. The section of import and sale of Medical Device : 「Excor Pediatric ventricular assist device」 and 「EZ-Regular」 is on the market.
Address: Creative Lab for Innovation in Kobe(CLIK)3F 6-3-7 Minatojima-Minamimachi Chuo-ku, Kobe 650-0047, Japan  (Contact Person Shinichi Sawada)
TEL: +81-78-304-6101 FAX: +81-78-304-6103
E-mail: s-sawada@cardio.co.jp

Carna Biosciences, Inc.

Major field:Drug Discovery

Miner field:Genomics

Miner field:Contract Research

Drug discovery business and drug discovery support business

Overview

Carna Biosciences, Inc. is a biotech company established in April 2003 in Kobe as a spin-off company from Japanese research unit of NV Organon and is listed on Tokyo Stock Exchange JASDAQ Growth.
We conduct research and development to discover novel kinase inhibitors and provide drug discovery supporting services based on the drug discovery platform technology that have been acquired through many years of research and development experiences.

Product / Service / PR

    Carna Biosciences is focused on the discovery and development of kinase inhibitor drugs to treat serious unmet medical needs in oncology, autoimmune and neurological diseases by inhibiting kinases that are important drivers for those diseases.
    Carna Biosciences also provides high quality kinase proteins, accurate screening and profiling services, assay kits and assay development that satisfy customer needs, and cell-based assay services, playing an important role in kinase inhibitor drug discovery conducted by global pharmaceutical companies.
Address: BMA 3F, 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047  (Contact Person Corporate Planning)
TEL: +81-78-302-7039 FAX: +81-78-302-6665
Web site: https://www.carnabio.com/english/ E-mail: ir-team@carnabio.com

Celaid Therapeutics Inc.

Major field:Regenerative Medicine

Miner field:Drug Discovery

Miner field:Outsourcing Business for Hospital

Development of new cell therapies for hematological and immunological diseases by using “Hematopoietic stem cells (HSC)”

Overview

Celaid Therapeutics is a startup biotech company in Japan to develop cell therapy products by using Hematopoietic stem cells (HSC), the source of human blood, for the treatment of hematological and immunological diseases, such as leukemia.
In the treatment of blood cancers, a certain amount of HSC must be transplanted to cure the disease. Our business aims to increase the number of HSC and provide them to hematological malignancy patients as a new innovative cell therapy product.

Product / Service / PR

    We primarily focus to develop cell therapy products that can solve various issues in current HSC transplantation by ex vivo expansion of HSC derived from umbilical cord blood. Compared to bone marrow transplants, cord blood-derived HSCs have the following advantages: shorter preparation time for procurement, less stringent HLA matching requirements, and lower risk of side effects after transplantation.
Address: Utokyo Entrepreneur Lab., South Clinical Research Bldg., 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8485, Japan  (Contact Person Atsuya Yamamura)
TEL: +81-50-3612-7767
Web site: https://celaidtx.com/en/ E-mail: contact@celaidtx.com

CellFiber Co.,Ltd.

Major field:Regenerative Medicine

Miner field:Genomics

Development of cell mass production solutions

Overview

We are developing a method for industrial mass production of cells using a novel culture technology.

Product / Service / PR

    We are developing "high-efficiency culture" solutions to efficiently obtain high-quality cells using "cell fiber" technology, which encapsulates cells and extracellular matrix in gel tubes of several hundred micrometers in diameter. As collaborators, we are searching for companies and research institutes that face challenges in cell culture, such as pharmaceutical companies and biotech companies.
Address: 〒113-8485  216 UT South Clinical Research Building, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8485, JAPAN  (Contact Person Aki Adachi)
TEL: 050-3645-1640
Web site: https://cellfiber.jp/ E-mail: adachi@cellfiber.jp

CHISHOKAKO CO.,LTD

Major field:Production Equipment

Miner field:Medical Equipment

CO₂BE MEDICAL ENGINEERING Inc.CO2BE

Major field:Medical Equipment

Miner field:Beauty and Health Care

Development and production of the carbon dioxide therapy equipment

Overview

Scientists of Kobe University Graduate School of Medicine founded this company on April 8, 2010 to develop the first “artificial Bohr effect” generator that delivers pure carbon dioxide transdermally into the muscle depth. The use of carbon dioxide to enhance muscle force was internationally applied under PCT and patented in Japan on December 4, 2009. The generator can work not only as a medical device, but also as a beauty care and a healthcare device.

Product / Service / PR

    The “artificial Bohr effect” generator increases blood flow and oxygen release from haemoglobin . We found that it enhances not only muscle-training effect but also muscle force even without muscle training in human and animals. The generator changes muscle fiber type from IIb (un-trained) to IId and IIa (trained and well-trained) without muscle training. This change is associated with an increase in mitochondria quantity and activity, which leads to an activation of lipid metabolism.
Address: 1-5-1 Minatojima-minami-machi, Chuo-ku, Kobe JAPAN 650-0047  (Contact Person Tanaka, Masaya)
TEL: +81-78-252-3107 FAX: +81-78-252-1916
E-mail: tanaka@neochemir.co.jp

COMNET Corporation

Major field:Distributor

Miner field:Contract Research

Providing equipment for test or design of medical devices (membership-based support)

Copan Japan Co., Ltd.

Major field:Medical Equipment

Sales of LBM® (Liquid Based Microbiology™) product lines that improves the efficiency of microbiological examination.

Overview

Focusing on sales of LBM® (Liquid Based Microbiology™) product lines manufactured by COPAN ITALIA SPA to major clinical laboratories and university/ base hospitals with optimal scientific education and training.

Product / Service / PR

    LBM® product lines are ready-to-use system, including FLOQSwabs®, flocked swab for collection and transfer of biological samples, and liquid medium in one pack: eSwab®, UTM® (Universal Transport Medium™), FecalSwab™ and others. We are supporting our customers to create better testing environment through providing such LBM® products as sample collection devises for laboratory automation: WASP® and WASPLab®.
Address: 5-5-2 Minatojima Minamimachi, Chuo-ku, Kobe-city, KIBC6F 659  (Contact Person Shinji Matsuura)
TEL: +81-78-599-9460 FAX: +81-78-599-9461
Web site: http://japanproducts.copangroup.com/ E-mail: Shinji.Matsuura@copangroup.com